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Abstract
Background The Swiss Federal Office of Public Health
demanded a nationwide HTA-registry for cervical total
disc arthroplasty (TDA), to decide about its reimburse-
ment. The goal of the SWISSspine registry is to generate
evidence about the safety and efficiency of cervical TDA.
Materials and methods Three hundred thirty-two cases
treated between 3.2005 and 6.2006 who were eligible for
5 years follow-ups were included in the study. Follow-up
rates for 3–6 months, 1, 2 and 5 years were 84.6, 74.4, 50.6
and 64.8 %, respectively. Outcome measures were neck
and arm pain, medication, quality of life, intraoperative and
postoperative complication and revision rates. In addition,
segmental mobility, ossification, adjacent and distant seg-
ment degeneration were analyzed at the 5-year follow-up.
Results There was significant, clinically relevant and
lasting reduction of neck (preop/postop 60/21 VAS points)
and arm pain (preop/postop VAS 67/17) and a conse-
quently decreased analgesics consumption and quality of
life improvement (preop/postop 0.39/0.82 EQ-5D points)
until the 5-year follow-up. The rates for intraoperative and
early postoperative complications were 0.6 and 7.2 %,
respectively. In 0.6 % an early and in 3.9 % a late revision
surgery was performed. At the 5-year follow-up, the
average range of motion of the mobile segments (88.2 %)
was 10.2. In 40.7 % of the patients osteophytes at least
potentially affecting range of motion were seen.
Conclusions Cervical TDA appeared as safe and efficient
in long-term pain alleviation, consequent reduction of pain
killer consumption and in improvement of quality of life. The
improvement is stable over the 5 years postoperative period.
The vast majority of treated segments remained mobile after
5 years, although 40.7 % of patients showed osteophytes.
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number of indications are covered. Total disc arthroplasty
(TDA) may be the most innovative and exciting develop-
ment in the history of spinal surgery [1]. It is a technique
for the management of degenerative intervertebral disc
disease in the younger adult population as an alternative to
fusion. The primary goals of arthroplasty are to reduce or
eliminate pain and restore and maintain normal segmental
motion. A theoretical advantage of an arthroplasty com-
pared with fusion is a reduction or elimination of adjacent
segment disease requiring later surgical intervention. Arti-
ficial discs are quite attractive to the surgeon and to the
‘‘internet informed’’ patient who, both, desire pain relief
with preservation of motion and with potentially decreased
risk of adjacent segment disease [1]. The devices are also
extremely attractive to the manufacturers and investors
because they are anticipated to take over a large portion of
the fusion market, representing billions of dollars of reve-
nue [1]. The potential economic effect of spine arthroplasty
in the United States is staggering with conservative figures
approximating $2.18 billion and 47.9 % of the market share
being captured by motion-sparing technology [2].
Currently, there is still inadequate evidence to promote
extensive use of artificial discs for cervical spondylosis,
despite promising short-term and intermediate clinical
outcomes. However, there is also insufficient evidence to
cease using them completely [3]. To date, several disc
prosthesis types have been implanted in patients, but
consistent data on their clinical results have been reported
only for a few of them (Bryan disc and Prestige disc,
Medtronic; Prodisc-C, Synthes; Moby-C, LDR-Spine;
Kineflex, SpinalMotion) [4–8]. The long-term stability,
durability and clinical efficiency of the prostheses are
unknown for the majority of implants so far.
Due to increased use, reports on high complication rates,
and uncertainty regarding treatment outcomes, a govern-
mentally mandated national registry for disc arthroplasties
and some other spine procedures was established in March
2005. Short-term outcomes of cervical disc arthroplasties
from the so-called SWISSspine registry were already
published [9]. The next step in the technology assessment
was the collection of the 5-year follow-up results which are
presented in the current article.
Materials and methods
The SWISSspine registry
The detailed setup of the registry was already reported [9].
The nationwide registry is ongoing since March 2005 and
documents the following data: surgeon-based intervention
and follow-up forms, patient based preoperative comor-
bidity form as well as pre- and postoperative North
American Spine Society outcome assessment instrument
for the cervical spine (NASS) and EuroQoL-5D [9]. In
addition an informed consent form is signed by each
patient. The registry runs on the generic registry platform
MEMdoc of the Institute for Evaluative Research in
Orthopedic Surgery at the University of Bern [10]. Since
the registry is a governmentally mandated quality and
technology assessment project, no approval of the local
ethics committee was needed.
Sample characteristics
Five-year follow-ups were initiated in 2011 and included
332 eligible patients, who were treated between March 1st
2005 and July 1st 2006. 55.4 % were female. Both genders
were on average 47 years old (SD 9 years; overall range
26–78 years). Bisegmental TDA was performed in 17.6 %
of patients. Figure 1 demonstrates proportions of different
comorbidities at the time of surgery.
The following devices were implanted in the considered
time period and included in the current report (in alpha-
betic order): Bryan and Prestige discs, Medtronic;
Discocerv, Scient’x; Moby-C disc, LDR Medical;
ProDisc-C, Synthes.
The analyses focused on 3–6 month, 1, 2 and 5 year
follow-ups. Surgeon-based follow-up rates for the given
timepoints were 84.6, 74.4, 50.6 and 64.8 %, respectively.
Despite trying to contact every patient for the 5-year fol-
low-up, 27.3 % of patients were not reached due to dif-
ferent reasons: patient moved away, surgeon moved away,
patient unreachable, follow-up appointment could not be
set up yet. Also, 7.5 % of other patients were lost to follow-
up due to unwillingness to participate, immobility or a
reoperation on the same level with a spondylodesis
(included in the revision rate).
Outcome measures
The following outcomes were assessed:
1. Neck and arm pain levels (VAS on NASS form).
2. Pain medication (based on pre- and postoperative
surgeon forms: none, NSAIDs, weak opiates, strong
opiates).
3. Quality of life (EuroQoL-5D, score ranging from -0.6
(worst possible QoL) to 1 (best possible QoL).
4. Complication and revision rates (based on pre- and
postoperative surgeon forms and informal patient
information).
5. Heterotopic ossification (HO) (only at the 5-year
timepoint: (a) X-ray based surgeon assessment with
an answer for ossification yes/no, (b) X-ray based
assessment of an independent assessor using McAfee
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classification) [11]. Category 0—when no HO present;
category I—when HO present in islands of bone within
soft tissue but not influencing the range of motion of
the vertebral motion segment; category II—when HO
possibly affecting the vertebral range of motion and/or
HO present between the two planes formed by the
vertebral endplates; category III—when the range of
motion of the vertebral endplates is blocked by the
formation of HO and/or postoperative osteophytes on
flexion–extension or lateral bending radiographs; and
category IV—when HO is causing inadvertent arthrod-
esis bridging trabecular bone continuous between
adjacent endplates and \3 of motion of lateral
flexion–extension radiographs [11]. To compare the
surgeon and independent assessors’ ratings, McAfee
categories 0–II were grouped as no ossification and
categories III and IV as ossification.
6. Segmental mobility (only at the 5-year timepoint:
sagittal X-ray measurements in flexion and extension).
7. Adjacent segment degeneration (ASD). The involved
surgeons indicated whether a progression of cranial,
caudal or both adjacent segments as well as of cranial,
caudal or both distant segments took place. Missing
answers on this question were regarded as no progres-
sion of the degeneration.
Statistical analysis
Wilcoxon rank-sum test was used for comparisons between
baseline and follow-up continuous variables such as pain
on VAS. When comparing proportions, the Chi square test
was used. a was set to 0.05 throughout the study. All sta-
tistical analyses were conducted using SAS 9.3 (SAS
Institute, Inc., Cary, NC, USA).
Results
The average follow-up time for the 5-year follow-up was
5.4 years (95 % confidence interval 5.3–5.5 years; range
4.1–6.5 years).
Pain levels and medication
There was a significant (p \ 0.001) and long-lasting neck
and arm pain relief from 60 and 67 points preoperative to
21 and 17 points postoperative at the fifth postoperative
year. Thus, the average neck and arm pain reliefs until
the fifth postoperative year were 41 and 52 points,
respectively. The course of neck and arm pain is shown in
Fig. 2.
The proportion of patients without medication increased
from preoperative 2.8 to 82.1 % at 5-years. Accordingly,
the proportion of patients consuming NSAIDs, weak and
strong opioids decreased from 85.6, 28.8 and 8.8 to 15, 1.7
and 2.3 %, respectively. Notably, the course of consump-
tion reduction between the first and the fifth postoperative
year was practically without change.
Quality of life
The improvement of quality of life was also significant and
long-lasting. Preoperatively, the EuroQoL-5D score was
0.39 and at the 5-year follow-up it was 0.82. The course of
postoperative quality of life is shown in Fig. 3.
Segmental mobility and ossification
According to surgeon assessments, 90.2 % of the segments
were mobile and 24.1 % of the segments had osteophytes.
Fig. 1 Comorbidities (%)
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The independent assessment of functional X-ray mea-
surements showed that in 11.8 % of the segments range of
motion (ROM) was between 0 and 2. The average range
of motion of the remaining mobile segments (88.2 %) was
10.2 (range 2–25, SD 5.5). In patients treated on two
levels, the caudal segments were on average 4.4 less
mobile than the cranial (8.2 vs. 12.6, p = 0.038).
Regarding osteophytes, 10.2 % of segments were classified
as McAfee grade 0, 49.1 % as grade I, 25.9 % as grade II,
13.9 % as grade III and 0.9 % as grade IV.
Complication and revision rates
During surgery a total of one blood vessel injury and one
dura lesion occurred in two patients. The rate for intraop-
erative complications was hence 0.6 %. Postoperatively, in
22 patients (7.2 %) either a dysphonia (n = 13) or a dys-
phagia (n = 9) was diagnosed. Two further patients
underwent an early revision surgery (0.6 %): one implant
removal and spondylodesis and another hematoma evacua-
tion were performed. Another 12 patients (3.6 %) underwent
Fig. 2 The course of neck and
arm pain over 6.5 years with the
95 % confidence intervals. All
available follow-ups per patient
considered
Fig. 3 The course of EQ-5D
score based quality of life over
6.5 years with the 95 %
confidence intervals. All
available follow-ups per patient
considered
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a different type of early re-intervention, which was not fur-
ther specified.
During follow-ups 13 patients (3.9 %) reported a dys-
phagia (n = 12) or a dysphonia (n = 2). One patient had
both dysphonia and dysphagia. In 11 of these 13 patients
the complication was new (11/332, 3.3 %). In all of these
patients except one the symptoms disappeared until the
2-year follow-up. In one patient the dysphagia was per-
sisting at his last available 3-year follow-up.
Over the course of the follow-up period 24 patients
(7.2 %) reported on 28 other complications, directly or
indirectly related to surgery (neck pain n = 10; cervical
radiculopathy on a new level n = 3; fibromyalgia n = 3;
facet joint syndrome n = 2; cervical distortion n = 2;
symptomatic stenosis on a new level n = 2; depression
n = 1; headache n = 1; subcutaneous pressure pain n = 1;
vertigo n = 1; spontaneous fusion n = 1).
During the five postoperative years 13 patients (3.9 %)
needed to undergo a revision surgery after hospital dis-
charge. Twelve patients were monosegmental (4.4 %) and
one bisegmental (1.7 %) cases.
Adjacent segment degeneration
Thirty-seven patients (11.1 %) developed signs of ASD
progression. Thirty-five out of 37 patients were treated on
one segment (total of 12.8 % for monosegmental patients)
and two other patients on two segments (total of 3.4 % for
bisegmental patients). Thirty patients out of 37 (total of 9 %)
had progression of cranial adjacent segment and 10 out of 37
patients (total of 3 %) had progression of caudal adjacent
segment degeneration. Thus, in three patients both cranial
and caudal segment degenerations were documented.
Eleven out of 37 patients and four other patients (in total
n = 15; 4.6 %) also had a progression of degeneration of a
distant segment. Progression of distant segment degenera-
tion occurred in 14 patients with a monosegmental surgery
(total of 5.1 % of monosegmental patients) and in one
patient with a bisegmental surgery (total of 1.7 % of bi-
segmental patients). Seven out of 15 patients (total of
2.1 %) had progression of a distant segment degeneration
cranially and nine (total of 2.7 %) caudally to the treated
segment. Thus, in one patient progression of both a cranial
and caudal distant segment were documented.
Discussion
The position of cervical total disc arthroplasty in the
hierarchy of spinal surgical procedures is not yet com-
pletely clear, as the hypothesized theoretical advantages of
the TDA in prevention of adjacent segment disease still
need to be confirmed in long-term studies, ideally with a
comparator. Short- and mid-term comparisons with the
gold standard—cervical fusion—are promising. In a ran-
domized study, Upadhyaya et al. [12] showed that arthro-
plasty had similarly excellent 2 years results as fusion, but
associated with a lower rate of secondary surgery and a
higher rate of neurological success. In 2011 Coric et al. [8]
reported that Kineflex-C was associated with a significantly
greater overall success rate than fusion while maintaining
motion at the index level at 2 years after surgery. In his
previous study from 2010 TDA prostheses (Bryan, Kine-
flex/C and Discover cervical discs) showed significantly
better clinical results, maintained motion at the treated
level, and tended toward less adjacent-level disease than
fusion [13].
Well studied is the evidence of cervical TDA in the
short- and mid-term perspective. Ren et al. [14] showed
good intermediate clinical outcome with the Bryan disc at
an average follow-up of 35 months. Good intermediate
results in 40 patients with the Prestige LP were shown by
Peng et al. [15] 2 years postoperative. However, the reports
with follow-ups longer than 5 years are still rare. Goffin
et al. [16] confirmed that the favorable clinical and func-
tional early postoperative outcome after Bryan TDA per-
sisted after 4–6 years. Recently, Quan et al. [17] published
8-year results of 21 patients with Bryan discs and con-
firmed favorable clinical and radiological outcome in the
majority of cases, also describing an increasing incidence
of heterotopic ossifications over time.
Pain relief, medication consumption and quality of life
The results of the current study showed significant and
stable neck and arm pain relief over the 5 postoperative
years. Postoperative arm pain was on average 5–6 VAS
points lower than neck pain. This improvement is reflected
in significantly reduced medication consumption and
increased quality of life. The reported short-term results of
cervical TDA in SWISSspine by Schluessmann et al. are in
accordance with our study. Slightly lower neck (21 vs. 24.8
in [9]), but very similar arm pain (17 vs. 17.6 in [9]) and
EQ-5D score were seen at 2-year results and 5-year results
in the registry.
Segmental mobility and ossification
14.8 % of segments had an advanced ossification affecting
the segmental ROM (McAfee grades III and IV) [11].
Another 25.9 % had an ossification potentially affecting
the segmental ROM (McAfee grade II). Both combined
make up 40.7 % of segments. A recent meta-analysis on
heterotopic ossification by Chen et al. [18] showed a
pooled prevalence of 11.1 % of advanced HO at the
12-month follow-up. This pooled prevalence increased to
Eur Spine J (2013) 22:1723–1730 1727
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16.7 % at 24 months. The pooled prevalence of any ossi-
fication was 44.6 % at 12 months and 58.2 % at 24-month
[18]. In our study, 89.2 % of patients had an ossification
Cgrade I at the 5-year follow-up. Many publications,
however, reported that HO was not affecting clinical
improvement [6, 19–24]. The clinical relevance of the low
grade ossifications is questionable. In the current analysis,
around 90 % of segments were mobile with an average
range of motion of 10 and stable postoperative neck pain
relief over time. Walraevens followed up 76 patients with
Bryan discs after 6 years and 87 % of them had mobile
devices; of the 26 cases with an 8-year follow-up 88 % had
mobile discs [25]. Other studies have reported segmental
ROM to be ranging between 7.3 and 10.6 at follow-ups
between the 2nd and 8th follow-up year [6, 16, 17, 25–27].
According to Kim et al. [26] the postoperative ROM of the
treated segments seems to be well preserved compared
with the preoperative one [25], or, as Wenger et al. [27]
reported, in comparison to the ROM of the adjacent levels.
Surgeon assessments and the independent assessment of
functional X-ray measurements were similar regarding
segment mobility. According to those assessments, between
9.8 and 11.8 % of the segments can be regarded as immobile.
Complications and revisions
A systematic review and meta-analysis of RCTs by Yu
et al. [28] reported an overall reoperation rate of 2.8 % for
cervical TDA and 7.5 % for anterior discectomy and fusion
at 2-year follow-up, which was significantly different.
Different prospective randomized single-level studies
comparing cervical TDA to anterior discectomy and fusion
reported variable revision rates between 1.8 and 11 %
[8, 13, 29–31]. Our rate for reoperation at 5.4 years follow-
up was 3.9 %, which lies well in between the range of the
rates seen in other studies.
The meta-analysis by Jiang et al. [32] showed a statistical
difference favoring cervical TDA over anterior cervical
discectomy and fusion regarding dysphagia incidence.
Practically, in all our patients the symptoms of dysphagia
and dysphonia disappeared until the 2-year follow-up, which
points to a temporary character of these complications.
Adjacent segment degeneration
Preservation of motion in total disc arthroplasty is expected
to decrease the risk for ASD in comparison with segmental
fusion. A recent experimental study by Barrey et al. [33]
showed that 1 and 2-level TDA generates better biome-
chanical conditions than arthrodesis at adjacent levels
limiting contribution of these segments to global ROM and
reducing the amount of their internal stresses. The current
status of clinical evidence on this issue remains uncertain.
Goffin et al. [34] reported a 92 % incidence of adjacent-
level degeneration after anterior discectomy and fusion.
Similarly, Hilibrand et al. [35] reported a cumulative risk
of 25 % for adjacent segment degeneration at long-term
follow-up after anterior discectomy and fusion. Recently,
Nunley et al. [36] reported 14.3 % of ASD after anterior
discectomy and fusion and 16.8 % after cervical TDA after
approximately 3 years postoperative and concluded on an
equivalent risk for both procedures. The recent meta-
analysis of randomized controlled trials (RCT) comparing
cervical TDA and anterior cervical discectomy and fusion
by Yang et al. [37] showed an average 8.8 % ASD rate
after cervical TDA in comparison to 13 % after fusion.
This difference was, however, not significant and the
authors encouraged more high-quality long-term and large
sample size RCTs. In our relatively large patient sample
with an average follow-up time of 5.4 years 11.1 % of
ASD and 4.6 % of distant segment degeneration were
documented. Our rate of ASD is not disagreeing with those
observed in other studies. Interestingly, the cranial ASD
rate was 3-fold higher than the caudal one. Another
important observation was that the rate of distant segment
degeneration was only half as high as the ASD rate.
Difficulties in SWISSspine long-term follow-ups
The execution of 5-year follow-up in this national registry
was complex and related to several factors: (1) the national
multi-centric multilingual character of the registry including
39 clinics and 54 surgeons in the 2005/06 time period, with
whom close (ideally personal) contacts needed to be kept,
(2) the need for communication with the treated patients
via their surgeon and their secretary and not via the data
collection center that initiated and led the follow-up project,
(3) difficulties to motivate surgeons and their staff to identify
and contact their patients, and to convince patients to present
for follow-up despite good clinical outcomes, (4) out of
pocket expenses for patients for radiography if a deductible is
a part of the insurance contract, which is very common in
Switzerland, (5) the long-term character of the study with
additional problems in reaching patients and surgeons in case
of change of address or place of work.
Limitations and strengths
The following limitations deserve mention. Being an
observational unmonitored study a potential underreporting
of surgeon-based outcomes like complication and revision
rates cannot be completely excluded. All surgeons partic-
ipating in the documentation are certified by the Swiss
Spine Society for conducting cervical TDA surgery, which
means that they have proven the essential training and
qualifications and have agreed to accurately document the
1728 Eur Spine J (2013) 22:1723–1730
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interventions. The accordance between the surgeon-based
and independent measurements of ROM shows a rather
conscientious documentation. An audit or any other control
mechanism in a national registry would need strong
financial and organizational resources and was considered
as not feasible by the stakeholders of the project.
Furthermore, no direct treatment comparator is included
in the SWISSspine documentation. A complete documen-
tation of a gold standard procedure like fusion in a national
registry would need additional and substantial administra-
tive and financial efforts, which were considered even less
feasible. A cost-effective solution to this weakness is, e.g.,
a cross-registry comparison that has recently been under-
taken for lumbar TDA in the SWISSspine and anterior
interbody fusion in the Spine Tango registry [38]. A within
registry benchmarking is also possible as this has been
shown for lumbar TDA in the SWISSspine registry [39].
On the other hand, the registry represents real-world and
nationwide data including different treatment centers and
implants. This is the first large series of 5-year follow-up of
a data pool with different types of cervical discs.
Conclusions
Cervical TDA provides a significant, clinically relevant and
stable neck and arm pain relief in the 5-year perspective.
Consumption of analgesics is consequently significantly
decreased and QoL improved to a considerable extent. The
procedure appears sufficiently safe.
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